Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin.

Journal: Diabetes, obesity & metabolism
PMID: 38828802

Abstract

AIM: To explore biomarkers that can predict the response of type 2 diabetes (T2D) patients to metformin at an early stage to provide better treatment for T2D.

Authors

  • Jianglan Long
    Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Qiushi Fang
    Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhe Shi
    Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
  • Zenghui Miao
    Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Dan Yan
    Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Keywords

External Resources

Popular Topics
Recent Journals